Google DeepMind, Meta and Isomorphic invest $300M in Biohub project

In short: Google DeepMind, Meta, and Isomorphic Labs are investing $300 million in the Chan Zuckerberg Biohub to help build data for a “virtual cell” project.

What happened

Google DeepMind, Meta, and Isomorphic Labs, an AI drug discovery startup, are jointly investing $300 million into the Chan Zuckerberg Biohub. Biohub is a nonprofit biomedical research group founded by Mark Zuckerberg and Priscilla Chan.

The money supports a larger $1.8 billion effort to build AI datasets. A dataset is a large, organized collection of information, like a well labeled library. Researchers use these datasets to train AI systems so they can “ask, predict, and answer biological questions digitally,” according to the reporting.

Biohub says the long-term goal is a “virtual cell.” You can think of this as a detailed computer model of how a human cell works (like a flight simulator, but for biology). Scientists could use it to test ideas and run simulated experiments before doing slower and more expensive lab work.

The effort also includes major US government support. The US Department of Energy plans to invest more than $500 million over the next five years, and the National Institutes of Health will contribute existing datasets and related resources from earlier federal funding.

Why it matters

If this works, it could speed up medical research by letting scientists try more ideas on computers first, then focus lab time on the most promising ones. That can matter for everyday people because faster research can improve how diseases are prevented, detected, and managed. It also shows how big tech companies and government agencies are increasingly pooling money and data to tackle health and biology.

Source: The Verge AI